Post by MedBound

Clinical Case Challenge : PCOS & Metformin A 26-year-old woman presents with irregular menstrual cycles, weight gain, acne, and laboratory evidence of insulin resistance classic features often associated with Polycystic Ovary Syndrome (PCOS). While Metformin is widely recognized as a first-line medication for Type 2 Diabetes Mellitus, its benefits extend beyond glycemic control. By reducing hepatic glucose production and improving insulin sensitivity, Metformin helps address the underlying insulin resistance frequently seen in women with PCOS. This improvement in insulin function can contribute to: ✅ Better hormonal balance ✅ Reduced androgen levels ✅ Improved ovulation ✅ More regular menstrual cycles ✅ Enhanced weight management Clinical Pearl: Managing insulin resistance is a key component in the treatment of PCOS, making Metformin an important therapeutic option for many patients. What is one of the primary mechanisms of action of Metformin? A. Increases insulin secretion from the pancreas B. Reduces glucose production in the liver C. Raises blood glucose levels D. Causes rapid weight gain Share your answer and reasoning in the comments! Join the discussion only at MedboundHub : https://lnkd.in/dg8wbetj #ClinicalCaseChallenge #PCOS #Metformin #MedicalEducation #ClinicalLearning #WomenHealth #Endocrinology #OBGYN #MedicalStudents #HealthcareProfessionals #MedBoundHub #Medicine #InsulinResistance #ClinicalPearls #CaseBasedLearning